Clinical trial

The Prevention Options for Women Evaluation Research (POWER) Cohort

NCT03490058

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-06-14

PhaseN/A

Study timeline

Study start (actual)2017-06-14Date precision: day

Registry last updated2021-12-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV/AIDSunresolved

Interventions

TruvadaDRUG · verified · RxNorm: Truvada

Sponsors & collaborators

University of Washingtonlead sponsor

Desmond Tutu HIV Foundationcollaborator

Wits Reproductive Health and HIV Institutecollaborator

Kenya Medical Research Institutecollaborator

United States Agency for International Development (USAID)collaborator

RTI Internationalcollaborator

Harvard Medical School (HMS and HSDM)collaborator

University of Pittsburghcollaborator

National Institute of Mental Health (NIMH)collaborator

Mapped research locations

Cape TownSouth Africa1 JohannesburgSouth Africa1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03490058 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.